Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Tablet Contract Manufacturing

Plain, coated, extended-release, chewable, dispersible and effervescent tablets made under your brand by GMP-licensed manufacturers in India.

Choosing a tablet manufacturer is mostly about the product type

Almost every Indian formulation plant makes tablets, so finding one is easy. Finding the right one is not. A plant that makes good immediate-release tablets may have no experience with extended-release matrices, bilayer tablets, or effervescent products, which need very dry rooms and special packing.

Some products also need their own facility. Penicillins and other beta-lactams, many hormones, and cytotoxic oncology drugs must be made in dedicated, segregated areas, so only some plants can take them at all.

We match your product to plants that already make that tablet type for your target market, and we share their approvals before you commit.

Tell us this to get a quote

  • Molecule(s) and strength
  • Tablet type: plain, film-coated, enteric, extended-release, chewable, dispersible, effervescent, bilayer
  • Target market(s) and whether bioequivalence data is needed there
  • Pack: blister type, strip, bottle or tube, pack size
  • Annual volume and first-order quantity
  • Your own formula and dossier, or the manufacturer's

What to check in a tablet manufacturer

Approvals for your market

WHO-GMP and a CoPP cover most emerging markets. For the EU, UK, US, Australia or PIC/S markets the site must be inspected by that regulator, and the dossier must carry bioequivalence data where it is required.

Experience with your tablet type

Extended-release, enteric-coated and bilayer tablets need validated processes and dissolution methods. Ask for products of the same type already supplied to your kind of market.

Dedicated facilities where needed

Beta-lactams, many hormones and cytotoxic drugs must be made in segregated or dedicated blocks. Ask which block your product would run in.

Dissolution and bioequivalence

For generics in regulated markets, the dissolution profile and a bioequivalence study against the reference product decide registration. Ask whether a study exists, against which reference product, and who owns it.

Dossier ownership

A manufacturer's ready CTD or ACTD dossier is fastest. Check whether it is licensed to you per country, or sold outright, and what happens if you change manufacturer.

Packing lines

Alu-Alu blisters for moisture-sensitive products, child-resistant packs for some markets, bottles with desiccant, and tubes for effervescent tablets. Confirm the line exists in-house.

Effervescent tablets need a different plant setup

Standard tabletsEffervescent tablets
How they workSwallowed whole, chewed or dispersedDissolved in water first; an acid and a carbonate react and release carbon dioxide
Production roomsNormal controlled humidityVery low humidity throughout granulation, compression and packing, because moisture starts the reaction early
PackingBlister, strip or bottleMoisture-proof tubes with a desiccant cap, or aluminium foil strips
Typical productsMost prescription and OTC medicinesVitamin C, calcium and vitamin D, zinc, electrolytes, paracetamol, aspirin, acetylcysteine
Label pointsUsualSodium content per tablet, which matters for patients on a low-salt diet

Only some Indian plants run dedicated low-humidity effervescent suites. If your product is effervescent, that is the first filter we apply.

How it works with PharmaTradz

1
Brief

You send the product, tablet type, market and volume.

2
Shortlist with approvals

Two or three plants that already make that tablet type, with their approvals and country of manufacture. Manufacturer names under a confidential disclosure agreement when the requirement is firm.

3
Samples and formula

Samples of an existing product, or development batches, dissolution work and stability for a new one.

4
Artwork and registration

Your brand and artwork, and the dossier for your market. Regulated markets need registration, and often a bioequivalence study, before supply.

5
Commercial batches

Production, release with a batch-wise CoA, and third-party pre-shipment inspection if you want it.

6
Repeat supply

Scheduled batches against your forecast with the same site and documents.

Problems we see most often

Dissolution failures in stability

The tablet passes at release but slows down after months in a hot, humid market. Ask for zone IVb (30°C/75% RH) stability data on the pack you will actually use.

Effervescent tablets that swell or fizz in the tube

Moisture got in during production or through the pack. Check the plant's humidity records and the tube and desiccant specification.

A dossier that does not match the product

The registered formula, site or pack differs from what is being made. Compare the dossier with the current batch record before you file.

Have a tablet product in mind?

Send the molecule, tablet type, market and annual volume. We will tell you which manufacturers fit and what documents they hold.

Send your requirement Talk to our team

Other contract manufacturing

Building your own brand across several products? See white label and third-party manufacturing, or the CDMO and contract manufacturing guide hub.

Frequently Asked Questions

It means a licensed manufacturer makes tablets to your specification and under your brand, while you handle marketing and distribution. You can use your own formula and dossier, or the manufacturer's existing product and dossier.

A smaller group of plants with dedicated low-humidity effervescent suites and tube-filling lines. Many make vitamin C, calcium, zinc and electrolyte products for both pharmaceutical and supplement markets. We shortlist by product, approvals and pack type.

For a generic medicine in the EU, UK, US and many other regulated markets, usually yes, unless the product qualifies for a waiver. Many emerging markets accept a dossier without one for older molecules. We check what your target regulator asks for before quoting.

It depends on the batch size of the manufacturer's equipment and the strength. Tablets usually have lower minimums than softgels or effervescent products. We share the actual figure with the quote.

Yes. Your brand appears as the marketer and the manufacturer is also named on the label. In India a marketer shares legal responsibility with the manufacturer for the quality of a medicine sold under its name (Drugs Rules 84D and 84E, in force since March 2021).

Yes, through plants that already make them for your type of market. These products need validated processes and dissolution methods, so we only shortlist plants with the same product type in their portfolio.

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us